3. Carriers: These include chronic HBV carriers and inactive HBsAg carriers. In the latter group, HBeAg and HBV DNA are not detected in the serum using PCR .

1. Chronic Hepatitis B is divided into HBeAg-positive chronic hepatitis B and HBeAg-negative chronic hepatitis B. The former shows positive serum HBsAg, HBV DNA, and HBeAg, while anti-HBe is negative; the latter displays positive serum HBsAg and HBV DNA, with persistent negative HBeAg and either positive or negative anti-HBe. Both types often exhibit persistently or repeatedly elevated serum ALT levels, or hepatocellular inflammation as revealed by liver tissue examination. Based on biochemical tests and other clinical and auxiliary examination results, these two types of hepatitis can further be categorized as mild, moderate, or severe.

2. Hepatic Cirrhosis: Hepatic cirrhosis is a result of the progression of chronic hepatitis B. It can be further divided into compensated cirrhosis and decompensated cirrhosis. The former may present with mild fatigue, loss of appetite, or abdominal distension, with abnormal ALT and AST levels, but without obvious signs of liver dysfunction. The latter often leads to severe complications such as esophageal and gastric variceal rupture, hepatic encephalopathy, and ascites. Many patients experience significant liver dysfunction, such as serum albumin levels below 35 g/L, bilirubin levels exceeding 35 µmol/L, and ALT and AST levels rising to varying degrees, with prothrombin activity (PTA) below 60%.

3. Carriers: These include chronic HBV carriers and inactive HBsAg carriers. In the latter group, HBeAg and HBV DNA are not detected in the serum (using PCR).

4. Latent Chronic Hepatitis B: Serum HBsAg is negative, but HBV DNA is present in the serum and/or liver tissue, along with clinical manifestations of chronic hepatitis B.

(2) Diagnosis of Hepatitis C

Patients with a history of blood transfusion, blood product use, or clear exposure to HCV—such as intravenous drug users or those who have undergone tattooing—may also be diagnosed. Clinical manifestations include general fatigue, loss of appetite, nausea, and right upper quadrant pain, occasionally accompanied by low-grade fever, mild hepatosplenomegaly, and in some cases, splenomegaly. A small number of patients may develop jaundice. However, most patients do not exhibit obvious symptoms, instead presenting as latent infections, often discovered only when ALT levels rise during routine health checkups. Hepatitis C can be divided into acute and chronic forms.

1. Acute Hepatitis C (1) Epidemiological History: Patients with a history of blood transfusion, blood product use, or clear exposure to HCV. The incubation period for acute hepatitis C after blood transfusion is 2–16 weeks (with an average of 7 weeks), while the incubation period for sporadic acute hepatitis C remains to be studied. (2) Clinical Manifestations: General fatigue, loss of appetite, nausea, and right upper quadrant pain—occasionally accompanied by low-grade fever, mild hepatosplenomegaly, and in some cases, splenomegaly. A small number of patients may develop jaundice. Some patients exhibit no obvious symptoms, instead presenting as latent infections. (3) Laboratory Examinations: ALT levels are often mildly or moderately elevated, with positive anti-HCV and HCV-RNA ≥1×10³. HCV-RNA often turns negative before ALT returns to normal, though there are also cases where ALT returns to normal while HCV-RNA remains positive. If three of the above criteria are met, or if (2) and (3) are combined, a diagnosis of acute hepatitis C can be made.
2. Chronic Hepatitis C (1) Diagnostic Criteria: When HCV infection persists for more than 6 months, or when the onset date is unknown and there is no history of hepatitis, but liver tissue pathology reveals chronic hepatitis, or when clinical symptoms, signs, laboratory tests, and imaging findings are comprehensively analyzed, a diagnosis can also be made. (2) Assessment of Disease Severity: The severity of the lesion can be determined based on the diagnostic criteria for liver inflammation and fibrosis revised jointly by the Infectious Diseases and Parasitology Branch and the Liver Disease Branch of the Chinese Medical Association (2000, Xi’an). HCV alone rarely causes severe hepatitis; however, when HCV is co-infected with HIV, HBV, or other viruses, or when patients consume excessive amounts of alcohol or use hepatotoxic drugs, severe hepatitis may develop. The clinical manifestations of severe hepatitis caused by HCV are largely similar to those of severe hepatitis caused by other hepatotropic viruses, and may present as acute, subacute, or chronic conditions. (3) Extrahepatic Manifestations of Chronic Hepatitis C: Extrahepatic clinical manifestations or syndromes may result from abnormal immune responses in the body, including rheumatoid arthritis, dry conjunctivitis and keratitis, lichen planus, glomerulonephritis, mixed cryoglobulinemia, B-cell lymphoma, and late-onset cutaneous porphyria. (4) Liver Cirrhosis and HCC: The most severe outcome of chronic HCV infection is liver cirrhosis and HCC caused by progressive liver fibrosis. (5) Mixed Infections: When HCV is co-infected with other viruses, or when infections overlap, these are collectively referred to as mixed infections. In China, HCV is often found in combination with HBV or HIV. (6) Recurrence of HCV Infection After Liver Transplantation: Hepatitis C often recurs after liver transplantation, and the progression of the disease is significantly faster than in patients with hepatitis C whose immune function is normal. Once liver cirrhosis develops in transplanted liver tissue, the risk of complications is higher than in patients with cirrhosis whose immune function is normal. Recurrence of hepatitis C after liver transplantation is related to HCV RNA levels at the time of transplantation and the degree of immunosuppression following transplantation. (7) Laboratory Examinations: ALT levels are often mildly or moderately elevated, with positive anti-HCV and HCV-RNA ≥1×10³. (3) Diagnosis of Other Types of Hepatitis For other types of hepatitis, in addition to epidemiological data, patients may exhibit general hepatitis symptoms such as fatigue, loss of appetite, and jaundice. However, pathogen detection remains the most reliable diagnostic tool. By analyzing hepatitis virus-specific antigens, antibodies, and viral nucleic acid test results, diagnoses for each type of hepatitis can be established. Anti-HAV IgM is positive for hepatitis A; for hepatitis D, in addition to HBV markers (HBV-M), serum HDAg, anti-HDV, anti-HDV IgM, and HDV RNA are all positive, and HDAg and HDV RNA are also present in liver tissue. Anti-HEV IgM is positive for hepatitis E, anti-HEV IgM is positive for hepatitis G, and TTV infection is detected with anti-TTV antibodies. (4) Differential Diagnosis The main characteristics of hepatitis include jaundice, gastrointestinal symptoms, hepatosplenomegaly, and liver function abnormalities. However, besides liver and biliary diseases, many other infectious and systemic illnesses can present with similar clinical manifestations. Although we now have pathogen-based diagnostic methods for each type of hepatitis, due to the large number of infected individuals and the potential for overlapping or mixed infections, differential diagnosis remains quite challenging. Below are some key distinctions:
3. Liver Damage Caused by Other Infectious Diseases ① Infectious Mononucleosis: Fever, pharyngitis, swollen lymph nodes, with abnormal lymphocytes accounting for over 10% of white blood cell count, positive heterophile agglutination tests, and rising serum EBV antibody titers. ② CMV Infection: Similar to EBV infection, CMV antibody titers rise while EBV antibody titers remain negative; viral isolation can be performed from blood, urine, sputum, and stool. ③ Salmonella infections, septicemia, tuberculosis, malaria, echinococcosis, amoebiasis, schistosomiasis, and other diseases share distinct etiological characteristics and supporting evidence from their respective pathogens.
4. Drug- and Alcohol-Induced Liver Damage This is the second most common liver disease after viral hepatitis. Antipyretic analgesics, tetracyclines, rifampicin, novocaine, sulfonamides, isoniazid, chloroquine, sodium aminosalicylate, erythromycin, 6-mercaptopurine, methyltestosterone, chlorpromazine, methyldopa, sedatives, oral contraceptives, cholecystography agents, and alcohol poisoning—all can cause drug-induced hepatitis, hepatocellular necrosis, and liver cirrhosis. This condition often has a clear history of drug use, with initial symptoms including fever, rash, itching, and eosinophilia in peripheral blood; when the same medication is re-administered, liver damage may recur, even with negative viral hepatitis markers.
5. Biliary Infections and Stones Chronic biliary infections and stones often accompany liver damage, while chronic hepatitis and liver cirrhosis frequently coexist with biliary infections and stones. These conditions often present with fever, upper abdominal pain accompanied by muscle tension, increased neutrophil counts, elevated direct bilirubin, alkaline phosphatase, and cholesterol levels; ALT levels may rise slightly. X-rays, ultrasounds, and CT scans can help identify stones and intrahepatic bile duct dilatation.
6. Malignant Tumors

<!-- translated-chunk:30/261 -->

Task output rules: Translate this markdown block from Chinese to English. Preserve markdown markers, links, and formatting. Keep headings and list structure unchanged. Return only the translated block.